Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness
Launched by UNIVERSITY OF WASHINGTON · Feb 10, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a new digital training program can help improve the use of a smartphone app called FOCUS for people with serious mental health conditions like schizophrenia, bipolar disorder, major depressive disorder, and schizoaffective disorder. The main goal is to see if patients can achieve the same positive results with FOCUS when they are supported by clinicians who have received training through this new platform.
To participate, individuals need to be at least 18 years old, speak English, have a diagnosed serious mental illness, and own a smartphone that can run the FOCUS app. Participants will use the app and receive guidance from trained clinicians. It's important to note that those planning to move or stop services at their mental health center in the next three months are not eligible for this study. This trial is currently looking for participants, so if you or someone you know may fit the criteria, consider joining to help improve mental health care options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chart diagnosis of a serious mental illness (i.e., schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder)
- • 18 years of age or older
- • English-speaking
- • Have access to a smartphone that can support FOCUS
- Exclusion Criteria:
- • • Plan to move or discontinue services at the participating community mental health center in the next three months
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, New Hampshire, United States
Dover, New Hampshire, United States
Saint Louis, Missouri, United States
St. Louis, Missouri, United States
Patients applied
Trial Officials
Dror Ben Zeev, PhD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials